Trade INSM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Insmed Incorporated (INSM) is trading at US$120.00, down 3.21% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$27.47B. Over the past 52 weeks, INSM has traded between US$90.39 and US$212.75. On Syfe you can trade INSM with $0 commission and add it to your watchlist.
| Previous close | US$123.98 |
|---|---|
| Market cap | US$27.47B |
| P/E ratio | 814.15 |
| 52-week range | US$90.39 – US$212.75 |
| Volume | 3.43M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Insmed Incorporated
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Year: 2000
Insmed Insider Sold Shares Worth $637,650, According to a Recent SEC Filing
Aug 19, 8:20 PM · MT Newswires
Insmed Insider Sold Shares Worth $31,964,810, According to a Recent SEC Filing
Aug 12, 9:07 PM · MT Newswires
Insmed Insider Sold Shares Worth $3,494,838, According to a Recent SEC Filing
Aug 7, 8:42 PM · MT Newswires
Insmed Incorporated (INSM) stock is trading at US$120.00, -3.21% from the previous close of US$123.98.
The market cap for Insmed Incorporated (INSM) stock is approximately US$27.47B.
The price-to-earnings ratio for Insmed Incorporated (INSM) is 814.15, based on the latest reported earnings.
The 52-week high for Insmed Incorporated (INSM) stock is US$212.75.
The 52-week low for Insmed Incorporated (INSM) stock is US$90.39.
Insmed Incorporated (INSM) does not currently pay a dividend.
Stay on top of INSM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
